Experimental & Molecular Medicine,
Journal Year:
2024,
Volume and Issue:
56(1), P. 100 - 109
Published: Jan. 5, 2024
Abstract
Soluble
receptors
are
soluble
forms
of
found
in
the
extracellular
space.
They
have
emerged
as
pivotal
regulators
cellular
signaling
and
disease
pathogenesis.
This
review
emphasizes
their
significance
cancer
diagnostic/prognostic
markers
potential
therapeutic
targets.
We
provide
an
overview
mechanisms
by
which
generated
along
with
functions.
By
exploring
involvement
progression,
metastasis,
immune
evasion,
we
highlight
importance
receptors,
particularly
cytokine
checkpoints,
tumor
microenvironment.
Although
current
research
has
illustrated
emerging
clinical
relevance
applications
remain
underexplored.
As
landscape
treatment
evolves,
understanding
targeting
might
pave
way
for
novel
strategies
diagnosis,
prognosis,
therapy.
Biomedicine & Pharmacotherapy,
Journal Year:
2024,
Volume and Issue:
178, P. 117177 - 117177
Published: July 24, 2024
Cytokines
regulate
immune
responses
essential
for
maintaining
homeostasis,
as
deregulated
cytokine
signaling
can
lead
to
detrimental
outcomes,
including
inflammatory
disorders.
The
antioxidants
emerge
promising
therapeutic
agents
because
they
mitigate
oxidative
stress
and
modulate
pathways.
Antioxidants
potentially
ameliorate
inflammation-related
disorders
by
counteracting
excessive
cytokine-mediated
responses.
A
comprehensive
understanding
of
pathways
the
interplay
with
is
paramount
developing
natural
targeting
helping
improve
clinical
outcomes
enhance
quality
life
patients.
Among
these
antioxidants,
curcumin,
vitamin
C,
D,
propolis,
allicin,
cinnamaldehyde
have
garnered
attention
their
anti-inflammatory
properties
potential
benefits.
This
review
highlights
interrelationship
between
cytokines-mediated
in
various
diseases
approaches
involving
antioxidants.
Journal of Translational Medicine,
Journal Year:
2023,
Volume and Issue:
21(1)
Published: Oct. 2, 2023
Cancer
stem
cells
(CSCs)
have
emerged
as
key
contributors
to
tumor
initiation,
growth,
and
metastasis.
In
addition,
CSCs
play
a
significant
role
in
inducing
immune
evasion,
thereby
compromising
the
effectiveness
of
cancer
treatments.
The
reciprocal
communication
between
microenvironment
(TME)
is
observed,
with
TME
providing
supportive
niche
for
CSC
survival
self-renewal,
while
CSCs,
turn,
influence
polarization
persistence
TME,
promoting
an
immunosuppressive
state.
Consequently,
these
interactions
hinder
efficacy
current
therapies,
necessitating
exploration
novel
therapeutic
approaches
modulate
target
CSCs.
this
review,
we
highlight
intricate
strategies
employed
by
evade
surveillance
develop
resistance
therapies.
Furthermore,
examine
dynamic
interplay
shedding
light
on
how
interaction
impacts
progression.
Moreover,
provide
overview
advanced
that
specifically
which
hold
promise
future
clinical
translational
studies
treatment.
Advanced Healthcare Materials,
Journal Year:
2023,
Volume and Issue:
12(25)
Published: July 1, 2023
Nanomaterials
that
mimic
the
catalytic
activity
of
natural
enzymes
in
complex
biological
environment
human
body
are
called
nanozymes.
Recently,
nanozyme
systems
have
been
reported
with
diagnostic,
imaging,
and/or
therapeutic
capabilities.
Smart
nanozymes
strategically
exploit
tumor
microenvironment
(TME)
by
situ
generation
reactive
species
or
modulation
TME
itself
to
result
effective
cancer
therapy.
This
topical
review
focuses
on
such
smart
for
diagnosis,
and
therapy
modalities
enhanced
effects.
The
dominant
factors
guide
rational
design
synthesis
include
an
understanding
dynamic
TME,
structure-activity
relationships,
surface
chemistry
imparting
selectivity,
site-specific
therapy,
stimulus-responsive
activity.
article
presents
a
comprehensive
analysis
subject
including
diverse
mechanisms
different
types
systems,
overview
synergistic
therapies.
strategic
application
treatment
can
well
be
game
changer
future
oncology.
Moreover,
recent
developments
may
pave
way
deployment
into
other
healthcare
challenges,
as
genetic
diseases,
immune
disorders,
ageing.
European journal of medical research,
Journal Year:
2024,
Volume and Issue:
29(1)
Published: Feb. 15, 2024
Abstract
Tumor
progression
and
eradication
have
long
piqued
the
scientific
community's
interest.
Recent
discoveries
about
role
of
chemokines
cytokines
in
these
processes
fueled
renewed
interest
related
research.
These
roles
are
frequently
viewed
as
contentious
due
to
their
ability
both
suppress
promote
cancer
progression.
As
a
result,
this
review
critically
appraised
existing
literature
discuss
unique
tumor
microenvironment,
well
challenges
future
opportunities
for
exploiting
develop
novel
targeted
treatments.
While
modulatory
molecules
play
an
important
suppression
via
enhanced
cancer-cell
identification
by
cytotoxic
effector
cells
directly
recruiting
immunological
stromal
TME,
we
observed
that
they
also
proliferation.
Many
cytokines,
including
GM-CSF,
IL-7,
IL-12,
IL-15,
IL-18,
IL-21,
entered
clinical
trials
people
with
advanced
cancer,
while
FDA
has
approved
interferon-alpha
IL-2.
Nonetheless,
low
efficacy
dose-limiting
toxicity
limit
agents'
full
potential.
Conversely,
Chemokines
tremendous
potential
increasing
immune-cell
penetration
microenvironment
promoting
beneficial
interactions.
When
combined
activate
lymphocytes,
producing
IL-2,
CD80,
all
which
strong
anticancer
effect.
This
phenomenon
opens
door
development
effective
combination
therapies,
such
therapies
can
reverse
escape,
chemotaxis
immunosuppressive
like
Tregs,
MDSCs,
TAMs.
Cancers,
Journal Year:
2025,
Volume and Issue:
17(1), P. 154 - 154
Published: Jan. 6, 2025
Inflammation
plays
a
crucial
role
in
wound
healing
and
the
host
immune
response
following
pathogenic
invasion.
However,
unresolved
chronic
inflammation
can
result
tissue
fibrosis
genetic
alterations
that
contribute
to
pathogenesis
of
human
diseases
such
as
cancer.
Recent
scientific
advancements
exploring
underlying
mechanisms
malignant
cellular
transformations
cancer
progression
have
exposed
significant
disparities
between
pediatric
adult-onset
cancers.
For
instance,
cancers
tend
lower
mutational
burdens
arise
actively
developing
tissues,
where
cell-cycle
dysregulation
leads
gene,
chromosomal,
fusion
gene
development
not
seen
counterparts.
As
such,
findings
adult
cannot
be
directly
applied
cancers,
unique
mutations
inherent
etiologies
remain
poorly
understood.
Here,
we
review
processes
chromosomal
instability,
tumor
microenvironment,
tumorigenesis
transformation
explore
current
therapeutic
interventions
maintain
and/or
restore
inflammatory
homeostasis.
Metabolism Open,
Journal Year:
2025,
Volume and Issue:
25, P. 100347 - 100347
Published: Jan. 9, 2025
The
highly
nuanced
transition
from
an
inflammatory
process
to
tumorigenesis
is
of
great
scientific
interest.
While
it
well
known
that
environmental
stimuli
can
cause
inflammation,
less
about
the
oncogenic
modifications
chronic
inflammation
in
tissue
microenvironment
bring
about,
as
how
these
set
off
pro-tumorigenic
processes.
It
clear
no
matter
where
factors
come
from,
maintaining
encourages
carcinogenesis.
In
addition
encouraging
angiogenesis
and
metastatic
processes,
sustaining
survival
proliferation
malignant
transformed
cells,
possibly
altering
efficacy
therapeutic
agents,
negatively
regulate
antitumoral
adaptive
innate
immune
responses.
Because
has
multiple
pathways
involved
metastasis,
gained
recognition
a
marker
cancer
desirable
target
for
therapy.
Recent
advances
our
knowledge
molecular
mechanisms
drive
cancer's
progression
demonstrate
promotes
metastasis
while
suppressing
anti-tumor
immunity.
many
solid
tumor
types,
including
breast,
lung,
liver
cancer,
stimulates
activation
oncogenes
impairs
body's
defenses
against
tumor.
Additionally,
alters
As
tactical
approach
treatment,
findings
have
underscored
importance
targeting
pathways.
This
review
highlights
role
development
focusing
on
its
impact
progression,
suppression,
therapy
resistance.
examines
current
anti-inflammatory
strategies,
NSAIDs,
cytokine
modulators,
STAT3
inhibitors,
addressing
their
potential
limitations.
emphasizes
need
further
research
unravel
complex
linking
identify
targets
specific
subtypes.
Cancers,
Journal Year:
2022,
Volume and Issue:
14(3), P. 552 - 552
Published: Jan. 22, 2022
Uncontrolled
inflammation
is
a
salient
factor
in
multiple
chronic
inflammatory
diseases
and
cancers.
In
this
review,
we
provided
an
in-depth
analysis
of
the
relationships
distinctions
between
uncontrolled
inflammation,
fibrosis
cancers,
while
emphasizing
challenges
opportunities
developing
novel
therapies
for
treatment
and/or
management
these
diseases.
We
described
how
drug
delivery
systems,
combination
therapy
integration
tissue-targeted
pathways
selective
strategies
could
overcome
current
agents
managing
treating
also
recognized
value
re-evaluation
disease-specific
roles
implicated
pathophysiology
cancers—as
well
as
application
data
from
single-cell
RNA
sequencing
success
future
discovery
endeavors.
Frontiers in Physiology,
Journal Year:
2023,
Volume and Issue:
14
Published: March 20, 2023
Stress
is
an
integral
part
of
life.
While
acute
responses
to
stress
are
generally
regarded
as
beneficial
in
dealing
with
immediate
threats,
chronic
exposure
threatening
stimuli
exerts
deleterious
effects
and
can
be
either
a
contributing
or
aggravating
factor
for
many
diseases
including
cancer.
Chronic
psychological
has
been
identified
significant
the
development
progression
cancer,
but
mechanisms
that
link
cancer
remain
incompletely
understood.
Psychological
stressors
initiate
multiple
physiological
result
activation
hypothalamic-pituitary-adrenal
(HPA)
axis,
sympathetic
nervous
system,
subsequent
changes
immune
function.
disrupts
homeostatic
communication
between
neuroendocrine
systems,
shifting
signaling
toward
proinflammatory
state.
Stress-induced
low-grade
inflammation
decline
surveillance
both
implicated
progression.
Conversely,
tumor-induced
inflammatory
cytokines,
apart
from
driving
tumor-supportive
microenvironment,
also
exert
their
biological
actions
distantly
via
circulation
therefore
adversely
affect
response.
In
this
minireview,
we
summarize
current
findings
on
relationship
focusing
role
stress-induced
neuroendocrine-immune
crosstalk.
We
discuss
underlying
potential
treatment
prevention.